Trial Profile
An Open Label Crossover Study In Healthy Older Male Subjects To Evaluate The Pharmacokinetics And Safety Of Sildenafil Following Fasted Administration Of An Orally Disintegrating Tablet Formulation Of Sildenafil Administered With Or Without Water Relative To Viagra Oral Tablet With Water.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Feb 2021
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- Sponsors Pfizer
- 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Mar 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Mar 2011 Planned end date changed from Feb 2011 to Mar 2011 as reported by ClinicalTrials.gov.